Poštovane koleginice i kolege,
Čast nam je i zadovoljstvo da vas pozovemo da učestvujete na 3. IBD konferenciji, koja će se održati 26. i 27. septembra 2025. godine u Tuzli, Bosna i Hercegovina.
Program “IBD akademije” pažljivo je osmišljen kako bi obuhvatio sve ključne aspekte u savremenom pristupu IBD pacijentima, od dijagnostike i terapije, preko uloge multidisciplinarnog tima, do razmatranja komorbiditeta i psihosocijalnih izazova u dugotrajnom zbrinjavanju pacijenata.
Neke od tema koje vas očekuju uključuju:
- Diferencijalnu dijagnozu IBD-a kroz kliničke, endoskopske i radiološke smjernice
- Korištenje i tumačenje fekalnog kalprotektina i uloga patohistologije
- Kada i kako koristiti ultrazvuk i endoskopiju u praćenju bolesti
- Savremene strategije za blag i umjeren oblik Crohnove bolesti i ulceroznog kolitisa
- Upotreba metotreksata, biološke terapije i praćenje terapijskih nivoa lijekova
- Teške kliničke slike poput perianalne bolesti, maligniteta i ekstraintestinalnih komplikacija
- Kontroverzne i inovativne teme: kanabis u IBD-u, hiperbarična komora, suplementi, probiotici
- Psihosocijalni aspekti bolesti: anksioznost, depresija, pravo na invaliditet, ishrana
Program će se realizovati kroz edukativna predavanja, prikaze slučajeva i panel diskusije sa ekspertima iz cijelog regiona a diskutovat ćemo o temama poput TBC-a, Clostridium difficile infekcije, tromboembolizma, kao i dijagnostičkih dilema kod atipičnih prezentacija bolesti.
Vjerujem da će program konferencije biti jednako koristan i za iskusne kliničare i za one koji su tek na početku svoje gastroenterološke karijere. Kroz otvorene diskusije, satelitske simpozijume i druženje u neformalnoj atmosferi, cilj nam je da podignemo kvalitet zbrinjavanja IBD pacijenata na viši nivo u cijelom regionu.
Ukoliko ste zainteresovani za učešće, više informacija o registraciji, smeštaju i zvaničnom programu možete dobiti putem tehničkog organizatora Freestyle d.o.o. Tuzla.
Radujemo se vašem dolasku i zajedničkom učenju u Tuzli!
Srdačno,
Prof. dr Mirela Bašić Denjagić, Predsjednica Asocijacije gastroenterologa i hepatologa u BiH Predsjednica organziacionog odbora
ORGANIZACIJA SIMPOZIJA
Organizatori:
Asocijacija gastroenterologa i hepatologa u Bosni i Hercegovini
Odjeljenje gastroenterologije i hepatologije Interne klinike JZU UKC Tuzla
Predsjednica:
Prof. dr Mirela Bašić Denjagić
Organizacijski odbor:
Prof. dr Predrag Jovanović
Prof. dr Ervin Alibegović
dr Majda Mehmedović
dr Selma Hodžić
Naučni odbor:
Prof. dr Ervin Alibegović
Prof. dr Milenko Bevanda
Prof. dr Rusmir Mesihović
Prof. dr Azra Husić
Prof. dr Nenad Vanis
Prof. dr Stevan Trbojević
Prof. dr Predrag Jovanović
Doc. dr Nadža Zubčević
Prof. dr Emil Babić
Doc. dr Amila Mehmedović
mr med. sci. Aida Pilav
dr Renata Tamburić
dr Tatjana Barać
dr Selma Hodžić
OPŠTE INFORMACIJE
MJESTO ODRŽAVANJA
Hotel Mellain, Tuzla
ul. Aleja Alije Izetbegovića br. 3
75 000 Tuzla
tel: 035 365-500
web: www.mellainhotel.ba
KOTIZACIJE
250,00 KM za specijaliste
200,00 KM za specijalizante
150,00 KM za medicinske sestre/tehničare
*Na navedene cijene se obračunava stopa PDV-a od 17%.
REGISTRACIJA
Potrebno je da ispunite online formu, koja će biti objavljena na web stranici www.kongres.ba ili putem e mail adrese: info@kongres.ba i registracija@kongres.ba
SMJEŠTAJ
HOTEL MELLAIN
ul. Aleja Alije Izetbegovića 3
75 000 Tuzla
HOTEL GRAND TUZLA
ul. ZAVNOBIH-a 13
75 000 Tuzla
HOTEL VERTIGOS
ul. Kulina Bana 2
75 000 Tuzla
TEHNIČKI ORGANIZATOR
FREESTYLE d.o.o. Tuzla
ul. Maršala Tita 109
75 000 Tuzla BiH
tel: +387 35 310 510
+387 35 310 511
e mail: info@kongres.ba
web: www.kongres.ba
PRELIMINARNI PROGRAM
PETAK 26.09.
09:00 – 09:30 Opening ceremony
09:30 – 09:45 Differential diagnosis of IBD. What are clinical, endoscopic and radiologic tips?
09:45 – 10:00 What is the proper way to use and interpret fecal calprotecin in patients with unknown disease, and with known IBD?
10:00 – 10:15 When is the best time for follow-up endoscopy, should we take biopsies and what are the difficulties in endoscopic scoring?
10:15 – 10:30 When to use ultrasound as a diagnostic tool and when as a monitoring tool?
10:30 – 10:45 What is the role of pathohistology in diagnosing and monitoring?
10:45 – 11:00 Discussion
11:30 – 11:50 Coffee break
12:00 – 12:15 How do you evaluate and treat mild Crohn’s disease?
12:15 – 12:30 How do you evaluate and treat mild to moderate ulcerative colitis? How should we be using 5-ASA in IBD and how do we optimize it?
12:30 – 12:45 How should methotrexate and calcineurin inhibitors be used in IBD.
12:45 – 13:00 How do we diagnose, treat and monitor mid and proximal small bowel Crohn’s disease
13:00 – 13:15 What is the first line approach to the diagnosis and treatment of perianal Crohn’s disease
13:15 – 13:30 Discussion
14:00 – 15:00 Lunch
15:00 – 15:15 What preparation should occur before initiating biologic therapy and why?
15:15 – 15:30 How should proactive therapeutic drug monitoring be considered in IBD patients. What are optimal cut-off values at what moment in what clinical scenarios?
15:30 – 15:45 What are the risks of advanced therapy and what are the challenges of communicating it with our patients? How to tell them everything they need to know without spooking them?
15:45 – 16:00 Can biologics be restarted after a prolonged drug holiday? Can they be reused after the initial loss of response?
16:00 – 16:15 Discussion
16:15 – 16:30 Coffee break
16:30 – 17:15 Panel discussion 45 minutes
TB and IBD
Clostridioides difficile and IBD
Thromboembolism and IBD
SUBOTA 27.09.
09:30 – 09:45 What is the role of probiotics, prebiotics and supplements in IBD
09:45 – 10:00 Can cannabis help our patients with IBD? What should we tell them when they ask about it?
10:00 – 10:15 What are the effects of hyperbaric chamber in the treatment of refractory IBD patients?
10:15 – 10:30 How can we manage steroid dependence and how can we minimize steroid use?
10:30 – 10:45 Functional disease and IBD. Treatment options
10:45 – 10:55 Discussion
11:10 – 11:25 Coffee break
11:25 – 12:10 Panel discussion
PSC and IBD – liver malignancy
Malignant melanoma and non-malignant skin cancer
IBD and colorectal cancer
12:10 – 13:00 Panel discussion
How should we screen our patients with IBD for depression and anxiety?
Do our patients have the right to disability?
What is the role of diet in children and in adults?
What are the most common supplements our patients use?
13:00 – 13:45
Blame it on IBD or maybe not
When IBD is not IBD
When 5-ASA is not the only culprit of renal failure in IBD patients
When iliopsoas abscess should not be operated by orthopedic surgeon
13:45 – 14:00 Conclusion and farewell
14:00 – 15 :00 Lunch
Sestrinska sesija – teme
Everyday Challenges of Nurses and Medical Technicians in the Field of IBD
How to Live with IBD?
The Role of the IBD Nurse in Improving the Quality of Life of IBD Patients
Fatigue in Patients with IBD
IBD Patient – Nurse/Medical Technician – Family
Biological Therapy in Patients with a History of Malignancy
Biological Therapy – The Experience of an IBD Nurse
Adherence in Patients with Chronic Inflammatory Bowel Disease
Kraj programa/End of program